These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10220632)

  • 1. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts.
    Liao Y; McGee DL; Cooper RS; Sutkowski MB
    Am Heart J; 1999 May; 137(5):837-45. PubMed ID: 10220632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts.
    Liao Y; McGee DL; Cooper RS
    Am J Cardiol; 1999 Jul; 84(1):31-6. PubMed ID: 10404847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
    Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
    JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematocrit and the risk of coronary heart disease mortality.
    Brown DW; Giles WH; Croft JB
    Am Heart J; 2001 Oct; 142(4):657-63. PubMed ID: 11579356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.
    van der Heijden AA; Ortegon MM; Niessen LW; Nijpels G; Dekker JM
    Diabetes Care; 2009 Nov; 32(11):2094-8. PubMed ID: 19875606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores.
    Knuiman MW; Vu HT
    J Epidemiol Community Health; 1997 Oct; 51(5):515-9. PubMed ID: 9425461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?
    Simmons RK; Sharp S; Boekholdt SM; Sargeant LA; Khaw KT; Wareham NJ; Griffin SJ
    Arch Intern Med; 2008 Jun; 168(11):1209-16. PubMed ID: 18541829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.
    D'Agostino RB; Grundy S; Sullivan LM; Wilson P;
    JAMA; 2001 Jul; 286(2):180-7. PubMed ID: 11448281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative importance of borderline and elevated levels of coronary heart disease risk factors.
    Vasan RS; Sullivan LM; Wilson PW; Sempos CT; Sundström J; Kannel WB; Levy D; D'Agostino RB
    Ann Intern Med; 2005 Mar; 142(6):393-402. PubMed ID: 15767617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?
    Diverse Populations Collaborative Group
    Heart; 2002 Sep; 88(3):222-8. PubMed ID: 12181209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The strength of the multivariable associations of major risk factors predicting coronary heart disease mortality is homogeneous across different areas of the Seven Countries Study during 50-year follow-up.
    Menotti A; Puddu PE; Adachi H; Kafatos A; Tolonen H; Kromhout D
    Acta Cardiol; 2018 Apr; 73(2):148-154. PubMed ID: 28786758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?
    Wang Z; Hoy WE
    Med J Aust; 2005 Jan; 182(2):66-9. PubMed ID: 15651963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.
    Shah N; Parikh V; Patel N; Patel N; Badheka A; Deshmukh A; Rathod A; Lafferty J
    Int J Cardiol; 2014 Feb; 171(3):390-7. PubMed ID: 24388541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
    Herrington DM; Fong J; Sempos CT; Black DM; Schrott HG; Rautaharju P; Bachorik PS; Blumenthal R; Khan S; Wenger NK
    Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension.
    Brown DW; Giles WH; Croft JB
    Am Heart J; 2000 Dec; 140(6):848-56. PubMed ID: 11099987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in cardiovascular risk factor levels in the Minnesota Heart Survey (1980-2002) as compared with the National Health and Nutrition Examination Survey (1976-2002): A partial explanation for Minnesota's low cardiovascular disease mortality?
    Wang H; Steffen LM; Jacobs DR; Zhou X; Blackburn H; Berger AK; Filion KB; Luepker RV
    Am J Epidemiol; 2011 Mar; 173(5):526-38. PubMed ID: 21273396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does job strain increase the risk for coronary heart disease or death in men and women? The Framingham Offspring Study.
    Eaker ED; Sullivan LM; Kelly-Hayes M; D'Agostino RB; Benjamin EJ
    Am J Epidemiol; 2004 May; 159(10):950-8. PubMed ID: 15128607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II).
    Mensah GA; Brown DW; Croft JB; Greenlund KJ
    Am J Prev Med; 2005 Dec; 29(5 Suppl 1):68-74. PubMed ID: 16389129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.
    Empana JP; Ducimetière P; Arveiler D; Ferrières J; Evans A; Ruidavets JB; Haas B; Yarnell J; Bingham A; Amouyel P; Dallongeville J;
    Eur Heart J; 2003 Nov; 24(21):1903-11. PubMed ID: 14585248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort.
    Vergnaud AC; Bertrais S; Galan P; Hercberg S; Czernichow S
    Prev Med; 2008 Jul; 47(1):61-5. PubMed ID: 18456313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.